Werewolf Therapeutics (HOWL) Asset Utilization Ratio (2022 - 2026)
Werewolf Therapeutics (HOWL) posted quarterly Asset Utilization Ratio of 0.51 for Q2 2026, up 340290.62% year-over-year from N/an in Q2 2025, and up 293254.83% on a QoQ basis from 0.0 in Q3 2025.
Werewolf Therapeutics (HOWL) Asset Utilization Ratio (2022 - 2026) Analysis & Trends
Werewolf Therapeutics has reported Asset Utilization Ratio for 5 years, with the latest figure at 0.51 in Q2 2026.
- Asset Utilization Ratio for Q2 2026 came in at 0.51, up 340290.62% year-over-year; the trailing twelve-month figure through Jun 2026 was 0.51 (up 340290.62% YoY), and the FY2024 annual result was 0.01, down 89.42% from the prior year.
- Asset Utilization Ratio grew to 0.51 in Q2 2026, from 0.0 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.51 in Q2 2026 and troughed at 0.0 in Q2 2025.
- A 5-year average of 0.09 and a median of 0.06 in 2024 frame the typical range for Asset Utilization Ratio.
- The widest annual swing landed in 2025, when Asset Utilization Ratio plunged 99.73%; it then jumped 340290.62% in 2026.
- A 5-year view of Asset Utilization Ratio shows it stood at 0.1 in 2022, then rose by 15.17% to 0.11 in 2023, then sank by 87.47% to 0.01 in 2024, then tumbled by 98.78% to 0.0 in 2025, then jumped by 293254.83% to 0.51 in 2026.
- Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.51 in Q2 2026, 0.0 in Q3 2025, and 0.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 0.90 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.54 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.13 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.13 |
| 10 | Werewolf Therapeutics | 20.90 Mn | 20.90 Mn | - | 0.51 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.51 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.01 |
| Dec 31, 2024 | 0.01 |
| Sep 30, 2024 | 0.02 |
| Jun 30, 2024 | 0.06 |
| Mar 31, 2024 | 0.09 |
| Dec 31, 2023 | 0.11 |
| Sep 30, 2023 | 0.14 |
| Jun 30, 2023 | 0.13 |
| Mar 31, 2023 | 0.12 |
| Dec 31, 2022 | 0.10 |
| Sep 30, 2022 | 0.05 |
| Jun 30, 2022 | 0.02 |